ClinicalTrials.Veeva

Menu

FRI a Method of Reading Cardiotocography (CTG) in Labor (FINIS)

I

Institute of Hospitalization and Scientific Care (IRCCS)

Status

Not yet enrolling

Conditions

Labor Complication

Treatments

Other: Interpretation of the CTG using FRI score
Other: Classic interpretation of the CTG

Study type

Interventional

Funder types

Other

Identifiers

NCT06481514
ID 6566

Details and patient eligibility

About

The objective of the study is to investigate the FRI's ability to identify cases requiring urgent intervention which will present an adverse perinatal outcome (respiratory acidosis, metabolic acidosis, Apgar index, etc.) compared to the classical interpretation of CTG.

Patients whose CTG in labor will be considered non-reassuring will be enrolled and randomized into two groups. The "Fetal Reserve Index" algorithm will be applied to the first group of patients.

The second group of patients will, however, be managed according to the usual protocols internal management.

Full description

Patients in active labor and diagnosed with category II CTG will be enrolled and randomized into two groups. Full randomization will be performed by Excel software by generating random numbers using the "Randomise (RAND)" function The "Fetal Reserve Index" algorithm will be applied to the first group of patients. In in these patients the fetal reserve index will be calculated every 10 minutes. At each of the components of the score will be assigned a score of 1 if the variable evaluated is considered normal, 0 if classified as abnormal. The different scores obtained (score from 1 to 8) will be classified into 3 risk categories: Score 5-8: green zone, Score 3-4: zone yellow, Score 1-2: red zone. An FRI of 1-2 (red zone) is to be considered as anomalous. For patients with abnormal FRI a 40 minute timer will be started within which it will be necessary to exit the "red zone". If such patients will not be able to exit the red zone within 40 minutes, an additional timer will be started of 30 minutes within which the birth will be completed. The birth will be completed immediately in case of sentinel events (prolonged bradycardia, detachment of placenta, cord prolapse).

The second group of patients will, however, be managed according to the usual protocols internal management.

Enrollment

290 estimated patients

Sex

Female

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Women in the active phase of labor who presented when they entered the room I delivered a negative admission test (i.e. a normoreactive CTG according to ACOG) and that subsequently present during labor a diagnosis of category II CTG
  • Single term pregnancy
  • Signature of informed consent

Exclusion criteria

  • Failure to sign the informed consent
  • Previous caesarean section (TOLAC)
  • Twin pregnancy
  • Gestational age <37 weeks
  • Known genetic/chromosomal syndromes and/or malformations, excluding heart disease without contraindication to vaginal birth

Exclusion criteria

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

290 participants in 2 patient groups

group A (FRI)
Active Comparator group
Description:
The "Fetal Reserve Index" algorithm will be applied to the first group of patients. In in these patients the fetal reserve index will be calculated every 10 minutes.. For patients with abnormal FRI a 40 minute timer will be started within which it will be necessary to exit the "red zone". If such patients will not be able to exit the red zone within 40 minutes, an additional timer will be started of 30 minutes within which the birth will be completed.
Treatment:
Other: Interpretation of the CTG using FRI score
group B (No FRI)
Active Comparator group
Description:
The second group of patients will, however, be managed according to the usual protocols internal management.
Treatment:
Other: Classic interpretation of the CTG

Trial contacts and locations

1

Loading...

Central trial contact

Angela BOTTA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems